AI assistant
El.En. — Investor Presentation 2019
Dec 4, 2019
4393_cp_2019-12-04_93f4f8b6-178d-4fca-a327-3fbbf657a197.pdf
Investor Presentation
Open in viewerOpens in your device viewer
COMPANY PRESENTATION
INTERMONTE - December 2019

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA
1.El.En.
- 2.Markets and Growth drivers
- 3.Our Products
- 4.Financial Highlights
- 5.Latest News
- 6. Multiples & Comparables

El.En.
A Primary Player Providing Medical, Industrial and Conservation Laser Solutions Worldwide
Hi-Tech company
Hi-Tech industrial group active in opto-electronics with proprietary technologies and know how developed over 35 years
Listed on the Milan Stock Exchange Star segment since 2000
Global Group

More than 20 companies active worldwide on several laser application segments and markets
Among the leaders in its space with a Worldwide distribution network

Progressively widening its worldwide presence registering continuous growth over the years More than 45,000 laser sources sold and 5% of revenue invested in R&D More than 120 patents
More than 90 R&D specialists

El.En. Worldwide



Long term market trends
Aesthetics:
- Aging population
- Growing global obesity epidemic
- Increasing desire of many individuals to improve their appearance
- Reduction in procedure costs, attracting a broader consumer base

9

Minimally invasive surgeries:
- Minimally painful procedures
- Reduced side effects and risks
- Hospitalization days reduction
- Savings by Private & National Health Systems
- ROI increase for surgical services providers
Long term market trends
Laser cutting applications:
- Enhanced flexibility, productivity and quality standards in manufacturing processes
-
New application verticals
-
Building and construction
- Minimal environmental impact


Laser marking:
- Products identification and traceability
- Minimal environmental impact

Medical & Aesthetic energy-based systems market
| \$ l l S i i U m o n |
2 0 1 4 |
2 0 6 1 |
2 0 2 1 |
C G A R |
C G A R |
|---|---|---|---|---|---|
| 1 4- 1 6 |
1 6- 2 1 |
||||
| l b l d l l i i i i G o a n o n- n a s e a n m n m a v v y |
|||||
| d l h i i i i t t t t t n v a s v e m e c a a e s e c r e a m e n |
|||||
| t s y s e m s |
6. 9 3 2 |
8. 4 3 7 |
1 3. 9 9 2 |
1 0 % |
1 1 % |
| b d E t t t t n e r g y a s e r e a m e n s y s e m s - |
2. 0 3 3 |
2. 6 0 7 |
4. 3 8 0 |
1 % 5 |
1 0 % |
| d h & k h B i S i i i t t o y s a p n g n g e n n g |
7 2 4 |
9 9 6 |
1. 9 6 5 |
% 1 7 |
% 1 5 |
| k S i j i t n r e e n a o n u v |
2 3 5 |
6 9 5 |
0 8 9 1. |
% 1 5 |
9 % |
| l H i a r r e m o v a |
3 5 3 |
3 4 1 |
3 3 3 |
-2 % |
0 % |
| i L t t t e g v e n r e a m e n s |
3 1 1 |
1 5 7 |
8 1 7 |
9 % |
% 4 |
| d A i t c n e r e u c o n |
9 6 |
1 1 0 |
1 2 5 |
7 % |
3 % |
| l i j i V t a g n a r e u v e n a o n |
n a |
1 0 5 |
3 3 2 |
n a |
% 2 6 |
| d l l P i i & t t t t g m e n e e s o n a o o r e m o v a |
8 0 |
9 9 |
1 4 2 |
1 1 % |
7 % |
| h O t e r |
1 2 6 |
1 6 7 |
2 0 7 |
% 1 5 |
% 4 |
| l T t o a |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
1 5 % |
1 0 % |
Source: Medical Insight Report
Key growth drivers:
- Increasingly aging population
- Desire to achieve or maintain youthful appearance
- Increase in healthcare spending
- Requirements for fast and minimally invasive surgical procedures
Reports n Reports' analysts forecast : Medical aesthetics market
2018 to 2023 10.6% CAGR

Industrial laser market
Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
- •Sheet metal cutting: technology breakthroughs leading to strong demand expansion
- •Laser marking for identification: traceability as a quality standard

MARKET STUDIES:
Technavio's analysts forecast :
"The global industrial laser market to grow at a CAGR of 10.24% during the period 2017-2021"

Growthdrivers
MEDICAL
- Stronger presence in body contouring and cellulite treatment market
- New laser systems for hair removal
-
Novel dermatologic treatment device
-
OEM urology partnerships
- New products pipeline
INDUSTRIAL
New manufacturing applications for medium power CO2laser sources
- Strong demand for high power laser sheet metal cutting systems in China and Europe
- Strong manufacturing presence in China

Our critical success factors
-
- Continuous innovation (breakthrough products)
-
- Flexibility and improvement of production capacity (new factories)
-
- Seeking regulatory clearances worldwide


Permanent Hair Reduction Highlights
QUANTA - THUNDER MT (Blended Alexandrite + Yag) – High end system. The fastest in the world with scanner technology
DEKA - MOTUS AX and MOTUS AY – Moveo Technology , virtually pain free also on dark skin types
ASCLEPION - NEW MEDIOSTAR with MONOLITH Handpiece 5kW diode -10 cm2 - 20 Hz




Vascular treatments Highlights
ASCLEPION – QuadroStarPRO YELLOW – 577 nm
QUANTA SYSTEM– 585 and DenaVE (US Version) – 585 nm


Rembrandt's Syndrome


Tattoo and Benign Pigmented Lesions treatments Highlights
QUANTA SYSTEM – DISCOVERY PICO PLUS & Q-PLUS C MT (blended)
Almost 2 GW peak power (Pico)











BODY CONTOURING Highlights
DEKA - ONDA COOLWAVES – the first system in the world based on Microwaves @ 2,5 GHz for localized fat accumulations, laxity, and cellulite reduction


MULTI PLATFORM TECHNOLOGY Highlights
DEKA – LUXEA – CE 0123 marked in 2019 by TUV Sud
The most complete multiplatform with
- •Diode laser handpiece for permanent hair reduction
- •IPL sets for skin tightening, skin rejuvenation, deeper vascular treatments and acne treatments
- •Active Q-switch probe for tattoo removal and pigmented lesions treatments
- •Nd:YAG 1064 nm probe for vessels treatments
- •Radio Frequency (RF) probe for skin rejuvenation and tightening
- •Er:YAG probe for micro ablative skin resurfacing
- Nd:YAP probe for non ablative skin rejuvenation
Total :15 different handpieces
•



PHYSIOTHERAPY Highlights
ASA LASER – M6 the only robotized system for pain removal
The multitarget Laser system created to apply MLS® Laser Therapy automatically and uniformly to the treatment area.

ASA LASER – HIRO TT
TT® is the ultimate application of Hilterapia®, creating new and innovative capabilities in the treatment of painful pathologies of the musculoskeletal system.


VAGINAL ATROPHY AND VAGINAL LAXITY Highlights
DEKA – MONA LISA TOUCH (MLT) WITH RF TOUCH
The most complete vaginal surgical multiplatform with:

• CO2
- •New single use probes for MLT
- • New single use applicators for Treatment of vaginal laxity (non-surgical vaginal tightening) and vulvar treatment, in particular labia Majora and Minora hypertrophy. Adjuvant in the treatment of disorders of lower urinary tract: mild SUI (Stress Urinary Incontinence) and related symptoms.

Single use RF Touch Probe

UROLOGY - Stones Management and BPH Highlights
QUANTA SYSTEM– Litho 35 W Holmium laser QUANTA SYSTEM – Cyber Ho 60 W Holmium laser QUANTA SYSTEM – Cyber Ho 100 W Holmium laser ASCLEPION / JENA SURGICAL MultiPulse HoPLUS 140 W Holmium laser
with integrated morcellator
35 W60 & 100 W 140 W 2018 vs 2017 : +51,6% 23
UROLOGY – Virtual Stone Basket
QUANTA – Virtual Stone Basket Effect – onboard of 100 W Holmium lasers to avoid stone retropulsion and to capture stone fragments


PENTA & PENTA CHUTIAN
•Automatic CNC machines with up to 20 kW fiber lasers onboard


BEVELING CUT our new laser special preparation for butt-welding metal sheet edges

Financial Highlights
IncomeStatement 9M-2019
| '0 E 0 0 u r o |
/ / 3 0 0 9 1 8 |
% | / / 3 0 0 9 1 9 |
% | % V a r. |
|---|---|---|---|---|---|
| d d i t u n a u e |
d d i t u n a u e |
||||
| d l M i e c a |
1 3 8 8 3 7 |
% 5 7 0 , |
1 7 0 7 6 1 |
% 6 0 4 , |
% 2 3 0 , |
| d l I i t n s r a u |
1 0 4 6 0 0 |
4 3 0 % , |
1 1 2 1 8 7 |
3 9 6 % , |
7 3 % , |
| l T R t o a e e n e s v u |
2 4 3 4 3 7 |
1 0 0 0 % , |
2 8 2 9 4 8 |
1 0 0 0 % , |
1 6 2 % , |
| G i r o s s m a r g n |
9 6 3 0 6 |
3 9 6 % , |
1 1 1 1 4 5 |
3 9 3 % , |
1 4 % 5 , |
| E B I T D A |
2 0 3 6 4 |
9 9 % , |
3 2 6 1 6 |
1 1 % 5 , |
3 % 5 7 , |
| E B I T |
2 0 0 0 7 |
8 2 % , |
2 6 4 4 5 |
9 3 % , |
3 2 2 % , |
| P I t r e a x n c o m e |
9 9 0 8 1 |
8 2 % , |
2 6 2 7 1 |
9 8 % , |
3 8 % 7 , |
| / / 3 1 1 2 1 8 |
/ / 3 0 0 9 1 9 |
||||
| d d i t u n a u e |
|||||
| f l i i i i N t t e n a n c a p o s o n |
6 2 6 4 1 |
0 8 9 5 1 |
|||
| 2 7 |
Cash Flow

Revenue breakdown by business

Revenue breakdown by area

New factories
Jena - Asclepion

Vicenza – ASA Laser
Wenzhou (2nd) – Penta Laser


| l l Eu i io ro m n |
|||||
|---|---|---|---|---|---|
| l C a p e p a n x |
2 0 1 8 |
d 2 0 1 9 t |
l T t o a |
||
| l T t o a c a p e x |
2 7 |
1 2 |
3 9 |
||
| f w h h: ic o l N t e w p a n s |
2 2 |
8 | 3 0 |
||
| 3 | 1 |
Revenue and EBIT% guidance


Minorities acquisition in China

Acquired 45% of Penta Chutian Wuhan and 29,7% of Penta Laser Wenzhoufor approx. 20 mln euros + 5 mln of euros Earn Out .
34Transaction funded with available cash No impact on financial consolidation and guidance

Minorities acquisition in China - Ratios
| l i E t q a e u y v u |
5 2 1 8 8 6 |
b '0 R 0 0 m |
|---|---|---|
| / / ( ) l f f i 3 0 9 2 0 9 E N F P 1 t n e r p r s e a e r e a s o v u |
4 6 7 8 7 5 |
b '0 R 0 0 m |
| l ( f h ) i i i i E W t t t n e r p r s e v a u e a e r u a n a c q u s o n |
5 0 8 8 7 5 |
b '0 R 0 0 m |
| 2 0 1 8 |
2 0 1 7 |
/ 9 2 0 1 9 |
|
|---|---|---|---|
| / l E V S a e s |
0 7 1 , |
0 7 9 , |
0 7 2 , |
| / V I A E E B T D |
1 6 7 , |
6 9 3 , |
1 1 8 8 , |
| / E V E B I T |
8 5 3 , |
8 3 2 , |
1 8 0 1 , |
| / P E |
9 9 9 , |
1 0 8 9 , |
1 9 2 5 , |


Elesta preliminary activities for IPO
- •50% currently owned – Net worth consolidation
- •2018 Revenue: €3 mln; 2018 Net Income: € 0,2 mln
- •Possible timing: first half 2020


Multiples
| / l l i i i F t t t n a n c a n v e s m e n s m e r m i l V E t n e r p r s e a e u |
@ 1 2 4 , 6 6 5 7 |
/ / 3 0 0 9 1 9 |
|
|---|---|---|---|
| f l i i i i N t t e n a n c a p o s o n |
0 8 @ 5 , |
/ / 3 0 0 9 9 1 |
|
| l. k E E M C t n a r e a p |
6 3 9 8 @ , |
3 3 0 0 € , |
|
| / ( ) l l S 8 % S E V 5 a e s a e s |
8 1 , |
||
| / ( ) E V E B I T 8 5 % E B I T |
1 9 2 , |
||
| / k l d i j. P B V A r c e o o a e u |
2 9 , |
||
| k h l d 's h i S E t t o c o e r q u y p e r s a r e |
1 1 5 , |
Comparables
| in m ln Am nts ou |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Se 3 0 h, 2 0 9 1 t. t p |
Pr ice |
Re ve nu e |
Va % r. Re v. |
E B I T |
E B I T % |
M K. Ca p. |
E V |
/ le E V Sa s ( *) |
/ E V E B I T ( *) |
/ k P Bo o lu Va e |
| / d l he M ica Ae ic t t e s |
||||||||||
| Cu te ra |
\$ 3 7, 3 9 |
\$ 1 3 0 |
1 1 % |
\$ ( ) 1 0 |
-8 % |
\$ 5 3 2 |
\$ 5 1 1 |
3, 0 |
n. a. |
1 2, 1 |
| de In M o |
\$ 4 1, 5 5 |
\$ 0 9 1 |
3 % 5 |
\$ 2 4 |
3 8 % |
\$ 3 3 0 1. |
\$ 6 1. 1 4 |
8, 0 |
2 0 1, |
8, 3 |
| Ve nu s |
\$ 3, 0 0 |
\$ 2 1 |
-2 % 4 |
\$ ( ) 2 2 |
8 8 % -1 |
\$ 9 0 |
\$ 0 6 1 |
6, 8 |
n. a. |
n. a. |
| d l S isr M ica am e |
\$ 0, 5 3 |
\$ 8 5 |
9 % |
\$ 1 6 |
1 8 % |
\$ 2 3 5 |
\$ 1 3 2 |
0, 8 |
4, 2 |
0, 7 |
| ic Lu tr on |
€ 2 7, 7 |
€ 6 2 |
2 9 % |
-€ 8 |
3 % -1 |
€ 2 0 0 |
€ 8 2 1 |
2, 2 |
n. a. |
2, 2 |
| du ia l In tr s |
||||||||||
| ho ics I P G P Co to n |
\$ 1 3 9, 4 2 |
\$ 1. 0 0 8 |
-1 1 % |
\$ 2 3 4 |
2 3 % |
\$ 7. 0 4 0 |
\$ 5. 9 6 5 |
4, 4 |
1 9, 2 |
3, 0 |
| im du ie Pr In tr a s |
€ 6, 8 1 1 |
€ 3 0 7 |
% -4 |
€ 1 1 |
3 % |
€ 0 1 7 |
€ 3 1 1 |
0, 8 |
2 8 1, |
0 1, |
| 's Ha La n se r |
3 3, ¥ 1 7 |
6. 8 8 0 ¥ |
-2 % 1 |
3 8 ¥ 5 |
% 5 |
3 3 8 0 ¥ 5. |
3 0 2 3 ¥ 7. |
0 4, |
6 7 7, |
4, 1 |
| ( ) l. E En 1 |
€ 3 3, 0 0 |
€ 2 8 3 |
1 6 % |
€ 2 6 |
9 % |
€ 6 4 0 |
€ 5 7 7 |
1, 8 |
1 9, 2 |
2, 9 |
(1) EV and multiplies as for previous slide
(*) Revenue,Ebit and earnings annualized

Comparables


" …and the best is yet to come…."
Nobel Prize for Physics Prof. Gérard Mourou
El.En. SPA
Enrico ROMAGNOLI Investor Relations Manager tel. +39 055-8826807 E-mail: [email protected]
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324
Contacts